Microdacyn60
Commercial- Indications
- Wound care, Eye care, Oral care
Company intelligence / Profile preview
Brill Pharma develops, manufactures, and markets innovative pharmaceutical products primarily for ophthalmology and dermatology. Their portfolio includes treatments for eye dryness, macular degeneration, ocular allergies, eyelid hygiene as well as nutritional supplements for ocular health. The company operates internationally with headquarters in Barcelona and has recently established a US subsidiary. It belongs to Bristol Laboratories Ltd., a major UK pharmaceutical group. Products are commercialized mainly in Spain with plans to expand into Ibero-American markets.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brill Pharma.